Drug Safety - Case Reports
Adis, Springer Healthcare
About the journal
Drug Safety - Case Reports is a journal published by Adis, Springer Healthcare in Switzerland. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 2199-1162 · 2198-977X
- Country
- Switzerland
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
Index listings
- PUBMED · 2017-09-20
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2019
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
104
Last recorded publication year
2019
h-index
17
i10-index
47
From OpenAlex open data (CC0).
Editorial & policy3
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Poisoning and overdose treatments
- Poisoning and overdose treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacovigilance and Adverse Drug Reactions
- Antibiotics Pharmacokinetics and Efficacy
Show all subjects (50)
- Pneumocystis jirovecii pneumonia detection and treatment
- Pharmacovigilance and Adverse Drug Reactions
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- International Law and Human Rights
- Pharmaceutical studies and practices
- International Arbitration and Investment Law
- Methemoglobinemia and Tumor Lysis Syndrome
- Eosinophilic Disorders and Syndromes
- Methemoglobinemia and Tumor Lysis Syndrome
- Legal principles and applications
- International Arbitration and Investment Law
- Cardiovascular Syncope and Autonomic Disorders
- Pharmacological Effects and Toxicity Studies
- Eosinophilic Disorders and Syndromes
- Pharmaceutical studies and practices
- Pharmacological Effects and Toxicity Studies
- Cardiovascular Syncope and Autonomic Disorders
- International Law and Human Rights
- Legal principles and applications
- Potassium and Related Disorders
- Immunodeficiency and Autoimmune Disorders
- Epilepsy research and treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Autoimmune Bullous Skin Diseases
- Electroconvulsive Therapy Studies
- Neonatal Health and Biochemistry
- Muscle and Compartmental Disorders
- Potassium and Related Disorders
- Blood disorders and treatments
- Immunodeficiency and Autoimmune Disorders
- Blood disorders and treatments
- Muscle and Compartmental Disorders
- Neonatal Health and Biochemistry
- Electroconvulsive Therapy Studies
- Autoimmune Bullous Skin Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Epilepsy research and treatment
- Schizophrenia research and treatment
- Cardiac electrophysiology and arrhythmias
- Schizophrenia research and treatment
- Cardiac electrophysiology and arrhythmias
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ